Friday, October 25, 2024

GET OUR FREE E-NEWSLETTER

“You may choose to look the other way, but you can never say again that you did not know.”

— William Wilberforce

Search

FDA Panel Endorses New Alzheimer’s Drug After Accelerated Approval

FDA Panel Endorses New Alzheimer’s Drug After Accelerated Approval

The newest Alzheimer’s drug is on its way for full regulatory approval after a U.S. Food and Drug Administration (FDA) advisory panel voted that the drug was beneficial in slowing cognitive decline. The drug is expected to be fully approved by July 6, 2023.1 In clinical trials the drug, known as lecanemab, demonstrated a 27 […]

Search in Site

To search in site, type your keyword and hit enter

Search